-
Safe’n’Sound®: Protection against needlestick injuries
January 6, 2021The latest issue of ‘Harro Höfliger’ is highlighted Safe’n’Sound, our parenteral passive safety device. Read more…
-
Our preservative-free ophthalmic device is highlighted in ‘The Pharmaceutical Post’ magazine
December 17, 2020The latest issue of ‘The Pharmaceutical Post’ is highlighting Ophthalmic Preservative-free devices. Read more…
-
Nemera announces the appointment of Véronique Kodjo as non-Executive member of the Board
December 14, 2020Nemera, today announced the appointment of senior leader Véronique Kodjo as a non-Executive member of its Board. She will…
-
Nemera and Noble’s strong collaboration featured in The Pharmaceutical Post’s special edition on Injectables
November 17, 2020Special dossier about the collaboration between Nemera and Noble in the magazine ‘The Pharmaceutical Post’
-
Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities
October 27, 2020Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes…
-
Seen in the press: Nemera’s article featured in September ‘Le Monde des Grandes Ecoles’ magazine
October 23, 2020Special interview from our VP innovation in the magazine ‘Le Monde Des Grandes Ecoles’
-
The untold story of Nemera’s inhalation franchise
October 20, 2020As a world leader in drug delivery devices, Nemera has been instrumental in the inhalation space for over 20…
-
Seen in the press: Nemera’s article featured in September ‘Drug Development & Delivery’
September 10, 2020Drug Development Delivery’s latest issue features Nemera’s article: ‘Mapping the regulatory strategy to better navigate electronic drug delivery device…
-
Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services!
July 28, 2020Nemera and Insight Innovation Center are celebrating one year of collaboration!
-
Seen in the press: Nemera’s article featured in June ‘Bioscience Today’
June 29, 2020The recently published “Bioscience Today” magazine includes an article from Nemera: “Nemera’s takes dermal treatments to millions of patients”.